[HTML][HTML] Purinoceptor: a novel target for hypertension

X Li, L Zhu, J Lv, X Cao - Purinergic signalling, 2023 - Springer
Hypertension is the leading cause of morbidity and mortality globally among all
cardiovascular diseases. Purinergic signalling plays a crucial role in hypertension through …

P2Y purinoceptors as potential emerging therapeutical target in vascular disease

M Schuchardt, M Tolle… - Current pharmaceutical …, 2012 - ingentaconnect.com
In the last two decades a tremendous development has been noticed in our understanding
of the purinergic system, consisting of heterogeneously expressed purinoceptor subtypes …

Regulation of renal function and blood pressure control by P2 purinoceptors in the kidney

J Van Beusecum, EW Inscho - Current opinion in pharmacology, 2015 - Elsevier
Highlights•Renal distribution of P2 purinoceptors in vascular, glomerular and tubular
structures.•P2 receptors are important for renal autoregulation and for regulation of renal …

[HTML][HTML] Purinoceptors, renal microvascular function and hypertension

G Zhengrong, MN Makled, EW Inscho - Physiological research, 2020 - ncbi.nlm.nih.gov
Proper renal blood flow (RBF) and glomerular filtration rate (GFR) are critical for maintaining
normal blood pressure, kidney function and water and electrolyte homeostasis. The renal …

[HTML][HTML] P2Y purinergic receptors, endothelial dysfunction, and cardiovascular diseases

D Strassheim, A Verin, R Batori, H Nijmeh… - International journal of …, 2020 - mdpi.com
Purinergic G-protein-coupled receptors are ancient and the most abundant group of G-
protein-coupled receptors (GPCRs). The wide distribution of purinergic receptors in the …

Purinergic signaling and blood vessels in health and disease

G Burnstock, V Ralevic - Pharmacological reviews, 2014 - ASPET
Purinergic signaling plays important roles in control of vascular tone and remodeling. There
is dual control of vascular tone by ATP released as a cotransmitter with noradrenaline from …

P2X receptors in the cardiovascular system and their potential as therapeutic targets in disease

V Ralevic - Current Medicinal Chemistry, 2015 - ingentaconnect.com
This review considers the expression and roles of P2X receptors in the cardiovascular
system in health and disease and their potential as therapeutic targets. P2X receptors are …

[HTML][HTML] Purinergic receptors mediate endothelial dysfunction and participate in atherosclerosis

XM Wu, N Zhang, JS Li, ZH Yang, XL Huang… - Purinergic …, 2023 - Springer
Atherosclerosis is the main pathological basis of cardiovascular disease and involves
damage to vascular endothelial cells (ECs) that results in endothelial dysfunction (ED). The …

Purinergic P2Y2 receptors mediate rapid Ca2+ mobilization, membrane hyperpolarization and nitric oxide production in human vascular endothelial cells

A Raqeeb, J Sheng, N Ao, AP Braun - Cell calcium, 2011 - Elsevier
In blood vessels, stimulation of the vascular endothelium by the Ca2+-mobilizing agonist
ATP initiates a number of cellular events that cause relaxation of the adjacent smooth …

[HTML][HTML] Purinergic pharmacology

F Ciruela, KA Jacobson - Frontiers in Pharmacology, 2019 - frontiersin.org
The purine nucleotides and nucleosides constitute important extracellular signaling
molecules acting as neurotransmitters and neuromodulators. Indeed, extracellular …